Immunologic Activity Alteration
Conditions
Brief summary
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
Detailed description
The proposed study is a cross sectional study that will be carried out among HCWs in three University hospitals namely Kasr Alaini , Ain Shams , and Zagazeg Hospitals, employing a quantitative survey. II-Study population Participants will be the HCWs at great risk of getting an infection which include those who are in direct contact with respiratory secretions. Inclusion criteria Age: From 25 to 60 years old Department: physicians and nurses from the operating room, critical care department, emergency department, pulmonology department. The potential participants will be given an information sheet and time to review this information before informed consent is sought. After the potential participants have agreed to be enrolled in the study, an informed consent will be obtained by the Investigator. III- Procedures and Data collection: Serum Collection and Interview A- Detecting Serum IgG against SARS-CoV2 Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization.(5) The sensitivity and specificity reported by the manufacturer for IgM are 88.2% and 99.0% respectively, and for IgG are 97.8% and 97.9%. B- Structured Interview questionnaire A structured - interview questionnaire using closed ended question format will be used to obtain information on: 1. Socio-demographic characteristics of the interviewees asking about age, sex, residence, education, occupation, department, Job title, hospital name, medical experience in years, marital status, living with family, and having children or not. 2. History of medical conditions, and history of performing procedures with transmission risk (date, place, type, duration, and frequency), 3. The use of personal protection, i.e., wearing of N95 masks, gloves, and gown, and consistent handwashing. 4. In addition, information will be collected regarding any clinical signs or symptoms in the worker past 3 months, including fever, cough, shortness of breath, or radiographically confirmed pneumonia.
Interventions
DIAGNOSTIC_TESTSerum SARs COV 2 IGg screening in health care workers
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization
Sponsors
Kasr El Aini Hospital
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Age: From 25 to 60 years old * Department: physicians and nurses from the operating room, critical care department, emergency department, pulmonology department.
Exclusion criteria
* pregnant * Age over 60 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of IGg seropositive health care workers | single measurement from each person collected over 2 months | health care workers who have positive IGg in seum |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Differentiation between low risk and high risk HCWs | 2 months through out duration of study | to know positive IGg persons and IGg negative persons to understand risk factors |
Countries
Egypt
Outcome results
None listed